(S)-tert-Butyl 1-neopentylpyrrolidin-3-ylcarbamate, 95.0%, 1g

Methyl 2-(4-fluorophenyl)-2-hydroxyacetate, 95+%, 10g

4-Methyl-1H-imidazole-2-carboxylic acid, 95.0%, 1g

1-Ethyl-7-(trifluoromethyl)-1,2,3,4-tetrahydroquinoline, 97%, 100mg

4-Bromo-2-nitroanisole>98.0%(GC)5g

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

2-(tert-Butylsulfonyl)aniline, 97%, 1g

3-Fluoro-4-methoxyacetophenone, 98.0%, 5g

Malonic acid, min. 99%, for synthesis, 500 g, glass packaging

(S)-Tetrahydrofuran-3-amine, 97.0%, 250mg

2-Isopropylpyridine, 95.0%, 25g

METHYL 6-BROMO-3-FLUORO-2-METHYLBENZOATE, 95.0%, 100mg

Benzyl 4-carbamimidoylpiperidine-1-carboxylate, 95.0%, 500mg